Skip to main content
. 2022 May 4;50(7):919–929. doi: 10.1177/14034948221092294

Table III.

Descriptive characteristics of the participants by sex and age: the Tromsø Study 2015–2016.

Women N=11,074 Men N=10,009
40–49 years n=3375 50–59 years n=3245 60–69 years n=2675 70–79 years n=1360 80–99 years n=412 40–49 years n=3053 50–59 years n=2788 60–69 years n=2502 70–79 years n=1315 80–99 years n=348
Body mass index, kg/m2 26.8 (5.2) 26.7 (4.9) 26.9 (4.7) 27.5 (5.0) 26.8 (4.5) 28.1 (4.2) 27.9 (4.0) 27.8 (3.9) 27.7 (3.9) 26.6 (3.5)
Waist circumference, cm 89.2 (13.3) 90.3 (12.7) 91.7 (12.5) 93.8 (12.9) 91.9 (11.8) 99.3 (11.8) 100.0 (11.0) 100.7 (11.2) 101.9 (10.9) 100.7 (10.0)
SBP, mmHg 116.6 (14.6) 123.0 (17.7) 132.5 (20.4) 143.5 (21.0) 152.2 (23.5) 126.7 (14.9) 130.9 (17.0) 135.8 (18.4) 140.4 (19.0) 144.4 (23.3)
DBP, mmHg 71.2 (9.3) 73.3 (9.7) 73.6 (9.7) 73.7 (9.8) 73.9 (10.7) 77.5 (9.4) 79.8 (9.8) 79.3 (9.6) 76.3 (9.7) 74.1 (10.2)
Total cholesterol, mmol/L 5.1 (0.9) 5.7 (1.0) 5.9 (1.1) 5.7 (1.1) 5.6 (1.1) 5.4 (1.0) 5.6 (1.0) 5.3 (1.1) 5.0 (1.1) 4.9 (1.1)
HDL-cholesterol, mmol/L 1.6 (0.4) 1.7 (0.5) 1.8 (0.5) 1.8 (0.5) 1.8 (0.5) 1.3 (0.4) 1.4 (0.4) 1.4 (0.4) 1.5 (0.4) 1.5 (0.4)
Triglycerides, mmol/L 1.2 (0.7) 1.4 (0.8) 1.5 (0.8) 1.4 (0.7) 1.4 (0.7) 1.9 (1.3) 1.8 (1.1) 1.6 (0.9) 1.5 (0.8) 1.3 (0.6)
HbA1c, % 5.4 (0.5) 5.7 (0.6) 5.8 (0.5) 5.9 (0.6) 6.0 (0.5) 5.5 (0.6) 5.7 (0.7) 5.8 (0.7) 5.9 (0.7) 6.0 (0.6)
Antihypertensives,a % 7.0 (237) 15.0 (486) 30.2 (808) 53.8 (731) 66.7 (275) 8.3 (253) 18.4 (514) 39.4 (986) 55.5 (730) 62.1 (216)
LLD,a % 1.8 (62) 7.6 (245) 20.0 (534) 34.3 (466) 32.3 (133) 4.5 (137) 11.9 (332) 25.1 (628) 39.9 (525) 39.7 (138)
MI,a % 0.2 (6) 0.4 (12) 1.8 (45) 5.6 (71) 11.0 (40) 0.8 (25) 3.5 (94) 8.1 (197) 15.0 (191) 22.9 (72)
Stroke,a % 0.7 (24) 1.3 (40) 2.5 (64) 4.4 (55) 9.1 (33) 0.8 (24) 1.9 (53) 4.4 (107) 8.1 (103) 13.7 (44)
Diabetes,a % 2.6 (89) 4.4 (142) 7.1 (189) 11.7 (159) 12.1 (50) 3.6 (111) 6.1 (170) 10.3 (257) 13.9 (183) 16.4 (57)
Cancer,a % 2.7 (89) 5.5 (173) 9.0 (232) 10.9 (138) 15.7 (58) 1.4 (43) 3.4 (93) 7.6 (183) 13.7 (176) 14.0 (46)
COPD,a % 0.5 (18) 1.3 (41) 4.0 (102) 5.6 (70) 8.6 (31) 0.5 (14) 1.4 (38) 3.6 (88) 5.8 (73) 9.0 (29)
Obesity, % 23.0 (776) 21.1 (684) 21.9 (582) 26.8 (363) 21.9 (89) 26.9 (821) 25.2 (703) 24.7 (615) 23.8 (313) 15.2 (52)
Hypertension, % 13.9 (468) 28.2 (914) 51.4 (1374) 77.7 (1053) 89.5 (367) 24.9 (759) 41.1 (1144) 62.3 (1558) 77.8 (1021) 82.1 (285)
Hypercholesterolemia, % 5.8 (196) 20.0 (646) 35.9 (956) 47.0 (637) 46.0 (188) 14.2 (432) 23.5 (652) 34.1 (849) 44.9 (589) 45.5 (158)
Smoking,a % 12.8 (430) 18.1 (581) 15.7 (416) 9.9 (132) 6.5 (26) 12.9 (392) 15.9 (4,41) 14.3 (355) 8.3 (108) 6.5 (22)
University education,a % 68.7 (2303) 54.8 (1763) 40.3 (1061) 24.9 (323) 12.8 (47) 56.3 (1711) 47.1 (1299) 43.8 (1079) 38.3 (482) 26.7 (83)

Values are means (standard deviations) or proportions (numbers). Number varies (20,479–21,020) due to missing values.

a

Self-reported.

SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycated haemoglobin; LLD: lipid-lowering drug; MI: myocardial infarction; COPD: chronic obstructive pulmonary disease; Obesity: body mass index ⩾30 kg/m2; Hypertension: blood pressure ⩾140/90 mmHg and/or self-reported use of antihypertensives; Hypercholesterolemia: total cholesterol ⩾7.0 mmol/L and/or low-density lipoprotein cholesterol ⩾5.0 mmol/L and/or self-reported use of LLDs; Smoking: current daily smoking.